Heidelberg Pharma AG (HPHA) — Cash Flow Reinvestment Rate
Latest as of May 2022:
0.01x
Heidelberg Pharma AG (HPHA) has a Cash Flow Reinvestment Rate of 0.01x as of May 2022, reinvesting €101.61K (capex €50.81K plus investments €-50.80K) from operating cash flow of €13.59 Million. Check Heidelberg Pharma AG (HPHA) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.01x
(Capex + Investments) / Operating CF
Total Reinvested
€101.61K
Capex + Investments
Operating Cash Flow
€13.59 Million
EUR
Capital Expenditures
€50.81K
EUR
Annual Cash Flow Reinvestment Rate for Heidelberg Pharma AG (None–None)
Year-by-year capital reinvestment analysis for Heidelberg Pharma AG. For live market cap and broader valuation context, see HPHA company net worth.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow